DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.65 Cr | ₹1.95 Cr | ₹1.61 Cr | - | - |
What is the latest Long Term Provisions ratio of DR LAL PATHLABS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹2.65 Cr |
| Mar2025 | ₹1.95 Cr |
| Mar2024 | ₹1.61 Cr |
| Mar2023 | - |
| Mar2022 | - |
How is Long Term Provisions of DR LAL PATHLABS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.65 Cr | 36.00 | |
| Mar2025 | ₹1.95 Cr | 21.23 | |
| Mar2024 | ₹1.61 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Long Term Provisions of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹32,039.7 Cr | 0.4% | -3% | 20% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,249.0 Cr | 1% | 3% | 14% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹100,952.0 Cr | 4.7% | 2.8% | -9.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,987.4 Cr | -2.3% | -1.9% | -4.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹66,504.2 Cr | -4.1% | -7.4% | 20.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,161.3 Cr | -2.3% | 2% | 7% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 0.4% |
-3% |
20% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses